Home > Protocol Summaries: Compounds > GSK2330672 Protocol Summaries: GSK2330672 GSKStudy ID Phase Title Status 114985 phase 1 A first time in human, single blind, randomized, placebo-controlled,dose escalating crossover study to evaluate the safety,tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in healthy volunteers Completed 116511 phase 1 A single blind, randomized, placebo-controlled, dose escalating study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic parameters of repeat doses of GSK2330672 in healthy volunteers, given alone and with a single day of dosing with GSK1614235 Completed
